Cord blood is an attractive cell source in regenerative medicine and represents an alternative to bone marrow. The aim of this study was to investigate whether human umbilical cord blood mononuclear (HUCBM) cells might be valuable in hepatic regenerative medicine. HUCBM cells differentiated in vitro into hepatocytes, as suggested by expression of albumin, cytokeratin-18, glutamine synthetase, α-fetoprotein, and cytochrome P450 3A4 at both mRNA and protein levels in a time-dependent fashion. In contrast, the hematopoietic phenotype was gradually lost, as demonstrated by disappearance of CD45 expression. The regenerative potential of HUCBM cells was tested by using a human-to-rat xenotransplant model in which HUCBM cells were intraportally injected into rats with D-galactosamine-induced hepatitis. Liver histology and biochemical markers of hepatic damage were determined. Presence of human cells was detected in blood and liver of both control and D-galactosamine-treated animals. Cell transplantation produced an improvement in both the histological damage and liver function, as demonstrated by plasma values of alkaline phosphatase, γ-glutamyl transferase, lactate dehydrogenase, and total and direct bilirubins. Results obtained suggest that HUCBM cells are capable of hepatic engraftment in this human-to-rat xenotransplant model and that transplantation of HUCBM cells may be a suitable therapy for liver disease.
INTRODUCTION
nonhematopoietic cell lineages, including hepatocytes (5, 14, 22) . These results suggest that UCBSCs are an attractive cell source in regenerative medicine and may Umbilical cord blood has become a valuable alternative source of hematopoietic stem cells for allogeneic represent an alternative option to BMSCs. Several studies have described quantitative gene protransplantation (1, 13) . Cord blood contains a larger amount of hematopoietic stem cells compared with bone filing in both embryonic and bone marrow stem cells (6, 20) . To our best knowledge, however, similar analymarrow (11) . The immaturity of umbilical cord blood stem cells (UCBSCs) affords them numerous advantages
ses have yet to be performed in UCBSCs. Accordingly, one of the aims of this study was to quantitatively anaover adult bone marrow-derived stem cells (BMSCs) in cell transplantation. UCBSCs show greater proliferation, lyze the gene expression of several hepatocyte markers in human umbilical cord blood mononuclear (HUCBM) repopulation, differentiation and expansion potential, and susceptibility to genetic manipulation compared cells at various stages of differentiation. Most cell transplantation experiments are carried out with BMSCs, and they produce a lower incidence of graft-versus-host disease (7, 11, 16, 17, 26) . in mice lacking their thymus (nude mice) or in mice with severe combined immune deficiency (SCID). More Recent reports demonstrated the capacity of UCBSC to differentiate both in vitro and in vivo into various recently, in utero transplantation has been used in differ- ent species to test cell therapy, based on the permissive streptomycin, 0.25 µg/mL amphotericin B, 300 µM monothioglycerol, and a combination of several recombienvironment of the developing preimmune fetus (18, 21, 28) . However, there is a need for experimental cell nant human growth/differentiation factors, including 20 ng/ml FGF-1, as well as 10 ng/ml each of FGF-2, LIF, transplantation models that imitate as closely as possible the actual in vivo situation in humans. The present study SCF, and HGF, as described elsewhere (7) . Culture medium was changed every 7 days to replenish growth/ describes a very simple human-to-rat xenograft model in which HUCBM cells are delivered via the portal vein differentiation factors. of rats previously immunosuppressed with both
Real-Time RT-PCR cyclosporine A and an anti-asialo GM1 antibody. We used this model in rats with D-galactosamine-induced Total RNA was obtained by using Trizol (Invitrogen, Barcelona, Spain) and quantified by fluorescent method hepatitis to investigate the potential therapeutic utility of HUCBM cells in liver disease.
with the Ribogreen RNA Quantitation Kit (Molecular Probes, Barcelona, Spain). Residual genomic DNA was MATERIALS AND METHODS removed by incubating RNA with RQ1 RNase-free Cell Culture Reagents DNase (Promega, Madison, WI). First-strand cDNA was synthesized using High-Capacity cDNA Archive Kit Dulbecco's modified Eagle's medium (DMEM), fetal (Applied Biosystems, Weiterstadt, Germany). The negabovine serum (FBS), phosphate-buffered saline (PBS), tive control (no added transcriptase) was performed in L-glutamine, penicillin, streptomycin, amphotericin B, parallel, and the reverse transcription reaction product human acid fibroblast growth factor (FGF-1), and huwas subsequently analyzed by PCR agarose gel electroman basic fibroblast growth factor (FGF-2) were from phoresis to ensure no genomic DNA contamination in Invitrogen (Paisley, UK). Bovine serum albumin (BSA), the RNA preparation. cDNA was amplified using Taq Histopaque, 4-(2-hydroxyethyl)-1-Piperazine-ethanesulMan Universal PCR Master Mix (Applied Biosystems) fonic acid (HEPES), monothioglycerol, human leukemia on an ABI 7000 (Applied Biosystems). TaqMan primers inhibitory factor (LIF), human stem cell factor (SCF), and probes for albumin (Hs00609411_m1), α-fetoprotand human hepatocyte growth factor (HGF) were from ein (Hs00173490_m1), cytokeratin-18 (Hs01920599_gH), Sigma (St. Louis, MO). Cyclosporin A was purchased glutamine synthetase (Hs00374213_m1), CD45 (Hs002 from Fluka (Seelze, Germany) and the anti-asialo GM1 36304_m1), CYP 3A4 (Hs00604506_m1), and GAPDH antibody was from Wako (Osaka, Japan).
(Hs99999905_m1) genes were derived from the comIsolation and Culture of HUCBM Cells mercially available TaqMan Gene Expression Assays From Umbilical Cord Blood (Applied Biosystems). Relative changes in gene expression levels were determined using the 2 −∆∆CT method as Human umbilical cord blood samples were obtained in heparinized tubes from full-term deliveries, under inpreviously described (10) . The cycle number at which the transcripts were detectable (CT) was normalized to formed consent, according to approved procedures at the Virgen de las Nieves Hospital (Granada, Spain). Samthe cycle number of GAPDH detection, referred to as ∆CT. ples were diluted 1:1 in DMEM medium supplemented with 10% FBS. Low-density hematopoietic cells were Western Blot collected after centrifugation at 800 × g for 20 min in Ficoll density gradient (Histopaque, 1.077 g/ml) followProtein extraction and Western blot were performed as described elsewhere (25). Cell lysates were prepared ing the manufacturer's instructions. Mononuclear hematopoietic cells were obtained from the interphase and in 0.25 mM sucrose, 1 mM EDTA, 10 mM Tris, and 1% protease inhibitor cocktail (Roche, Mannheim, Gerwashed twice with sterilized PBS. Pellet was resuspended in lysis buffer (150 mM NH 4 Cl, 1 mM KHCO 3 , many). Samples containing 40 µg of protein were separated by sodium dodecyl sulfate-polyacrylamide gel 0.1 mM Na-EDTA, pH 7.4) and incubated for 5 min at 4°C to deplete erythrocytes. After washing once with electrophoresis (9% acrylamide) and transferred to nitrocellulose. Nonspecific binding was blocked by preincu-PBS, pellet was again resuspended.
Cell viability, determined by the trypan blue dye exbation of the nitrocellulose in PBS containing 5% nonfat dry milk for 1 h. HUCBM cells were grown on glass coverslides for immunodetection of human markers. Albumin was defreshly isolated mononuclear cells from human cord blood. Due to limitation in the number of cells isolated tected using an anti-human albumin antibody conjugated with fluorescein (DakoCytomation, Alb/FITC, F 0117, from cord blood, these experiments had to be carried out in different phases. HUCBM cells from the same batch dilution 1:100). Cytokeratin-18 was detected using an anti-human CK-18 antibody conjugated with fluorescein were distributed among the groups of rats receiving cell transplantation. (Abcam, ab7798, dilution 1:10), α-fetoprotein was detected using an anti-human α-fetoprotein antibody conAnimals were sacrificed under anesthesia with sodium pentobarbital at 24, 48, and 72 h posttransplantajugated with rhodamine (Santa Cruz Biotechnology, Inc. AFP, sc-8108. Dilution 1:100), and CD45 was detected tion, and blood and liver were removed. Blood was collected in tubes containing heparin and centrifuged to using an anti-human CD45 antibody conjugated with phycoerythrin (Santa Cruz Biotechnology, Inc., CD45, separate plasma from cells. The liver was divided into three pieces. The first piece was for histological analysc-1187, dilution 1:100).
Prior to immunostaining, cells were rinsed in 0.01 M sis. The second was for flow cytometry analysis. The third was kept in RNAlater (Ambion, Austin, TX) and PBS and fixed for 20 min in 2% paraformaldehyde/PBS. Later on, cells were rinsed in PBS, transferred for 5 min used for total RNA isolation. into a 0.1% Triton X-100/PBS solution and rinsed again Determination of Liver Damage Markers in Plasma in PBS before adding the antibodies. The coverslides were left overnight at 4°C in the presence of the diluted Plasma activities of aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, γ-glutamyl antibodies and then rinsed in PBS before mounting them with Fluoromount-G (SouthernBiotech, 0100-01) for transferase, and lactate dehydrogenase, and plasma concentrations of total and direct bilirubins and albumin microscopic observation with a Zeiss Axiophot fluorescence microscope.
were determined using commercial kits and an autoanalyzer Cobas Integra 400 (Roche Diagnostics, Basel, Transplantation Experiments Switzerland). All procedures involving rats were approved by the Histology Animal Care Committee of the University of Granada and conformed to European Union Animal Care RegulaLivers were rinsed in saline solution, minced, fixed for 6 h at room temperature with 4% paraformaldehyde tions.
The design of the transplantation experiments is in 0.01 M PBS, and then transferred into PBS. Small liver pieces always taken from the same lobe were emshown in Figure 1 . Sixty-six male Wistar rats weighing 350 g were used and received different treatments. D- bedded in epoxy resin (Electron Microscopy Sciences, Embed 812) and semithin (1 µm) sections were obtained Galactosamine was administered the day before cell transplantation or sham operation (day −1) at a dose of using a Leica Ultracut R ultramicrotome. Morphological evaluation was performed in toluidine blue-stained (1% 250 mg/kg in a single IP injection. Cyclosporin A was administered intramuscularly and daily, starting day −1 toluidine blue in 1% borax on a hot plate) sections using a Zeiss Axiophot microscope. For the histological analyat a dose of 15 mg/kg. The anti-asialo GM1 antibody was administered on day −1 at a dose of 100 µl/rat in a sis, all samples (n) described in Figure 1 were used. single IP injection.
Confocal Microscopy Animals were divided into eight groups. Group C received no treatment (control). Group G received D- Detection of human cytochrome P450 3A4 was performed in liver tissue using a rabbit policlonal anti-CYP galactosamine. Group C+Ab+Cy received immunosup- 3A4 antibody diluted at 1:1500 (Abcam) and an anti-1.08 mM disodium hydrogen phosphate, 1.10 mM potassium hydrogen phosphate, 400 IU/ml collagenase IV, rabbit IgG secondary antibody conjugated to rhodamine (rabbit IgG CyTM3-linked, Amersham). Cell nuclei and 20 mg BSA/ml. The cell suspension was filtered through a 100-µm nylon mesh, and a 1-ml aliquot of were stained using Hoechst 33342 (Sigma). Confocal images were obtained using a Leitz DMRB microscope was incubated for 20 min with 20 µl of the antibody. Fluorescent cells were analyzed in a FACS Vantage equipped with a Leica TCS-SP5 scanning laser confocal imaging system. flow cytometer (Becton Dickinson Immunocytometry System, San Jose, CA) equipped with a Coherent EnterFlow Cytometry prise laser (150 mW at 488 nm, 60 mW at UV), counting 10,000 cells/s. For this study, all samples (n) deThe presence of human CD45+ cells was investigated in peripheral blood and liver. Blood was incubated with scribed in Figure 1 tion. The appearance of the liver parenchyma of control In order to characterize the cells, various markers of hepatocytes (albumin, CK-18, and glutamine syntheand D-galactosamine-treated rats is shown in Figure 8 .
In comparison with controls, the most remarkable histotase), hepatic progenitor cells (α-fetoprotein), hepatic metabolism (cytochrome P450 3A4), and leukocytes logical findings in D-galactosamine-treated rats were steatosis, hepatocyte ballooning, and leukocyte infiltra-(CD45) were investigated at both mRNA and protein levels at 7, 14, and 21 days postincubation. Messenger tion. The damage was more severe in periportal areas. HUCBM cells were traced in peripheral blood and RNA levels were analyzed by real-time RT-PCR, while protein levels were studied by immunofluorescence liver. Confocal microscopy, flow cytometry, and realtime RT-PCR were used for this purpose. Although hutechniques and Western blot.
Real-time RT-PCR results showed that HUCBM man CD45+ cells could not be detected in blood, quantitative RT-PCR results showed presence of human cells expressed albumin, α-fetoprotein, CK-18, and glutamine synthetase mRNAs, with detection of all markers GAPDH in this tissue (not shown). In contrast, cells expressing human CYP 3A4 were detected by confocal at day 7 postincubation (Fig. 2A-D) . Maximum expression of albumin and CK-18 mRNAs was at day 14, microscopy ( Fig. 5) , and human CD45+ cells were detected by flow cytometry (Fig. 6 ) in the liver of rats whereas maximum expression of α-fetoprotein and glutamine synthetase mRNAs was at day 21. Freshly iso-(both control and experimental hepatitis rats). A higher percentage of human cells was detected in liver of Dlated cells did not express either mRNA ( Fig. 2A-D) .
Immunofluorescence analysis revealed that cultured galactosamine-damaged rats than in liver of controls also subjected to cell transplantation (Fig. 6) . Human HUCBM cells expressed albumin, α-fetoprotein, and CK-18 (Fig. 3A-C) . Both round and spindle-shaped GAPDH was also detected in the liver by real-time RT-PCR (not shown). cells were positive for albumin and α-fetoprotein (Fig.  3A, B) . Cells incubated in the absence of growth/differThe presence of human cells in liver of rats was also demonstrated by Western blot (Fig. 7) . Human CYP entiation factors were used as negative controls for immunofluorescence experiments, and no positive cells for 3A4 was detected in liver of rats treated with D-galactosamine and subjected to HUCBM cell transplantation. any of the selected markers were found in these cultures (not shown). Albumin, α-fetoprotein, CK-18, and gluta-CYP 3A4 was also found, although at lower levels, in controls that received a portal injection of HUCBM mine synthetase were also detected at protein level by Western blot in cultured cells but not in freshly isolated cells, supporting the flow cytometry data shown in Figure 6 . cells (Fig. 4A-C) , supporting the immunostaining analysis.
The histological analysis shown in Figrue 8 revealed that there was a progressive normalization of the liver Cytochrome P450 3A4 (CYP 3A4) was analyzed as a marker of liver metabolism, and the results are shown parenchyma that was nearly complete at 72 h posttransplantation in those rats with hepatitis that received in Figures 2F and 4D . CYP 3A4 protein levels increased in a time-dependent manner in cultured HUCBM, sug-HUCBM cells (G+Ab+Cy+HUCBM). Steatosis and disorganization of the hepatic parenchyma were still appregesting that metabolic function improves with time in the presence of growth and differentiation factors. Simiciable in rats with hepatitis that did not receive HUCBM cells (G+Ab+Cy+Sham) (Fig. 8) . lar results for CYP 3A4 mRNA levels were obtained by real-time RT-PCR.
Liver function was assessed by determining plasma activities of aspartate and alanine aminotransferase Expression of human CD45, a leukocyte marker, was (AST and ALT), alkaline phosphatase (AP), γ-glutamyl group G (hepatitis), which suggests that there was a clear effect due to HUCBM cells. transferase (GGT), and lactate dehydrogenase (LDH), and plasma concentrations of albumin, total and direct bilirubin (TB and DB) ( Table 1) . AST, ALT, AP, GGT, DISCUSSION LDH, TB, and DB values significantly increased in the group with experimental hepatitis (group G), suggesting Previous reports (7, 15) on the capacity of human mononucleated cells from umbilical cord blood to differena single injection of D-galactosamine induced severe hepatic damage and cholestasis.
tiate into hepatocyte-like cells are confirmed by results of the in vitro study reported in this article. HUCBM All of these parameters were close to control levels in the rats with hepatitis that underwent cell transplantation cells were isolated and plated in the presence of a cocktail of growth/differentiation factors for a maximum of (G+Ab+Cy+HUCBM) ( Table 1) . AP activity was even below levels in healthy rats. Cell transplantation resulted 21 days, as described by others (7). Albumin, α-fetoprotein, CK-18, and glutamine synthetase mRNAs were in a complete restoration of TB, DB, GGT, and LDH values. TB also decreased in controls that received cell expressed by cells as early as 7 days postincubation but their maximum expression was at 14 and 21 days. Extransplantation (C+Ab+Cy+HUCBM). No statistically significant improvement was observed in sham-operated pression of albumin, α-fetoprotein, CK-18, and glutamine synthetase proteins was confirmed by Western rats with hepatitis (G+Ab+Cy+Sham) compared with Two different morphologies, round and spindle volved in many aspects of metabolism (including that of xenobiotics) (3), whose expression increased in a timeshaped, could be observed in the cultures. Our Western blot and RT-qPCR assays did not allow us to distinguish dependent fashion in the presence of growth and differentiation factors and paralleled the disappearance of the which markers were expressed by each cell type. However, immunofluorescence experiments not only conhematopoietic phenotype. To our best knowledge, this is the first report that describes the progressive loss of firmed the Western blot results but also revealed that both round and spindle-shaped cells expressed a hepato-CD45 expression and the increase in CYP 3A4 expression in cultured HUCBM cells. cyte-like phenotype, as demonstrated by expression of albumin and α-fetoprotein. Other authors only found exTaken together, these results suggest that: i) cells present in the mononuclear fraction of human cord pression of hepatocyte markers in round cells (7, 15) . The spindle-shaped cells seen in our cultures might be blood express CD45 but do not express detectable amounts of albumin, α-fetoprotein, glutamine synthemesenchymal cells, which are present in cord blood and have been shown to have the capacity to transdifferentitase, or CK-18; ii) HUCBM cells have the capacity to differentiate in vitro into functional hepatocyte-like ate into hepatocytes (12, 27) . A noteworthy result is that hepatic engraftment was observed in both control and injured rats. Engraftment The general goal of our investigation is to deliver HUCBM cells to the liver so that they engraft and differwas much less frequent in the liver of control versus injured rats, an expected finding because liver injury has entiate into hepatic cells and, subsequently, repair liver function and damage. Adult stem cell transplantation been proposed as a stimulus for differentiating extra hepatic stem cells into hepatocytes (2, 23) . might be a feasible treatment option for liver dysfunction. We recently reported the intraportal transplantation Plasma biochemical data indicated that treatment with D-galactosamine induced severe liver damage, which of human CD34+ stem cells from umbilical cord blood to control rats and rats with thioacetamide-induced liver supports the histological data. Strikingly, alkaline phosphatase, γ-glutamyl transferase, lactate dehydrogenase, cirrhosis (19). CD34+ cells were detected in the blood within 15 days after the transplantation, but they did not and total and direct bilirubin values were closer to control values (group C) in animals with hepatitis that reengraft in the liver. We concluded that the human cells were rejected by the rats despite administration of imceived HUCBM cell transplantation than in those that did not. This improvement in liver function was supmunosuppressive therapy with cyclosporine A.
In the present study we chose a rat model of acute ported by the normalization of the hepatic parenchyma seen in the histological analysis. Therefore, cell therapy hepatitis induced by IP injection of D-galactosamine (9) because of the lack of hepatic engraftment reported in with HUCBM cells had a positive effect on experimental hepatitis. the chronic model of liver injury (thioacetamide) (19). Furthermore, this acute model mimics the histological In summary, these results provide direct evidence that mononuclear cells isolated from umbilical cord findings observed in the human disease, and typical alterations of hepatitis appear after a single injection of D- blood are capable of hepatic engraftment in this humanto-rat xenotransplant model. We believe that one of the galactosamine, in contrast to the 4-month period required to induce experimental cirrhosis with thioacetamide. The strengths of our model is its simplicity; human cells can be infused into rats in a very straightforward fashion. main histological findings after D-galactosamine administration were steatosis, hepatocyte ballooning, and inOur results also demonstrate that HUCBM cells may be a suitable source of cell transplantation for liver disease. flammatory cell infiltration.
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